Skip to main content
. Author manuscript; available in PMC: 2015 Feb 16.
Published in final edited form as: Ann Surg Oncol. 2014 Jul 8;21(13):4174–4180. doi: 10.1245/s10434-014-3858-4

Table 4.

Final Multivariate Model

Variable Hazard Ratio 95% C.I. p value
Female gender 0.87 0.44 – 1.71 0.69
Age at presentation 1.00 0.98 – 1.02 0.89
Race (Non-Caucasian vs. Caucasain) 1.54 0.74 – 3.21 0.25
Graves’ disease 3.00 0.33 – 27.54 0.33
Toxic multinodular goiter 0.51 0.06 – 4.38 0.54
# co-morbidities 0.91 0.77 – 1.06 0.23
Diabetes 0.43 0.10 – 1.90 0.27
Heart rate 1.02 1.00 – 1.03 0.04
Goiter on exam 0.94 0.54 – 1.63 0.82
Uptake % 1.03 1.01 – 1.05 <0.01
TSH ≤ 0.01 uIU/mL 2.05 1.00 – 4.18 0.05
T3 > 8 pg/mL 0.91 0.53 – 1.58 0.74
Free T4 > 5 ng/dL 2.08 1.20 – 3.62 0.01
RAI dose < 13 mCi 2.97 1.34 – 6.55 <0.01
Methimazole 2.55 1.22 – 5.33 0.01
>1 anti-thyroid medication 1.18 0.57 – 2.45 0.65

Significant items are indicated in bold type.

TSH, thyroid stimulating hormone, RAI, radioactive iodine, IU, international units, mL, milliliters, pg, picograms, ng, nanograms, dL, deciliters, mCi, milli-Curies